ArticleCurrent neuropharmacology2011
Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists.
Article in Current neuropharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Illicit Drug-Derived Volatile Organic Compounds as Markers for Application in Noncontact Detection Technology.Chemical record (New York, N.Y.) · 2026Review
- Comprehensive examination of demographic, psychological, cognitive, biochemical, and genetic profiles of methamphetamine addicts.Journal, genetic engineering & biotechnology · 2025Article
- Artificial intelligence approaches for anti-addiction drug discovery.Digital discovery · 2025Review
- Factors Influencing Illicit Drug Substance Abuse and Its Perceived Psychosocial Impact Among Individuals Undergoing Deaddiction Treatment at Male Drug Rehabilitation Centers of Eastern Nepal.Addiction & health · 2025Article
- Public Perception Towards Drug Abuse in South Korea: The Effects of Overconfidence and Affirmation.Psychiatry investigation · 2024Article
- Exploring prevention and control mechanisms of youth substance use: a case of North Wollo and Waghimra, Northeast Ethiopia.Frontiers in public health · 2024Article
- Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis.Signal transduction and targeted therapy · 2023Article
- Understanding the epidemiology of substance use in India: A review of nationwide surveys.Indian journal of psychiatry · 2023Review
- An Increase in Peripheral Temperature following Cocaine Administration Is Mediated through Activation of Dopamine D2 Receptor in Rats.Life (Basel, Switzerland) · 2022Article
- Community Pharmacists' Perceptions towards the Misuse and Abuse of Pregabalin: A Cross-Sectional Study from Aseer Region, Saudi Arabia.Healthcare (Basel, Switzerland) · 2021Article
- Rewiring the Addicted Brain Through a Psychobiological Model of Physical Exercise.Frontiers in psychiatry · 2019Review
- Cardiorespiratory Fitness Predicts Greater Vagal Autonomic Activity in Drug Users Under Stress.Substance abuse : research and treatment · 2019Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
IDARS is an acronym for the International Drug Abuse Research Society. Apart from our scientific and educational purposes, we communicate information to the general and scientific community about substance abuse and addiction science and treatment potential. Members of IDARS are research scientists and clinicians from around the world, with scheduled meetings across the globe. IDARS is developing a vibrant and exciting international mechanism not only for scientific interactions in the domain of addiction between countries but also ultimately as a resource for informing public policy across nations. Nonetheless, a lot more research needs to be done to better understand the neurobiological basis of drug addiction - A challenge for IDARS scientists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.